Streptococcus Salivarius Subsp Salivarius BIO5 – Toxicity Evaluation of a Possible Probiotic Strain

α
Vera Fantinato
Vera Fantinato
σ
Camargo HR
Camargo HR
ρ
Sousa ALOPilleggi
Sousa ALOPilleggi

Send Message

To: Author

Streptococcus Salivarius Subsp Salivarius BIO5 – Toxicity Evaluation of a Possible Probiotic Strain

Article Fingerprint

ReserarchID

J922A

Streptococcus Salivarius Subsp Salivarius BIO5 – Toxicity Evaluation of a Possible Probiotic Strain Banner

AI TAKEAWAY

Connecting with the Eternal Ground
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu

Abstract

Probiotic bacteria, which are traditionally studied to aid intestinal functions, are also currently being researched for benefits in other parts of the body such as the oral cavity. In the case of throat infections caused by bacteria, which traditional treatment involves antibiotics, some researchers are studying the possibility of introducing special strains of commensal bacteria into the mouth that can specifically inhibit the tonsillitis agent Streptococcus pyogenes for both prevention and treatment of such disease. A PCR assay was used to identify Streptococcus salivarius subsp salivarius. Therefore, tests for the complete absence of toxicity of these strains are required to ensure their safe use in human trials. In this research, we evaluated the new Streptococcus salivarius subsp salivarius BIO5 strain for toxicity factors, as follows: clinical, ophthalmic lesions, behavioral observations, mortality, anatomopathological examination, biopsy, hematology, serum biochemistry, and urine analysis. This strain, isolated from the oral cavity and with bacteriocinogenic activity against S. pyogenes, showed a complete absence of toxicity and thus it may be used in replacement therapy as a probiotic.

References

17 Cites in Article
  1. Vera Fantinato,Heloísa Camargo,Ana Sousa (2018). Probiotics study with Streptococcus salivarius and its ability to produce bacteriocins and adherence to KB cells.
  2. Charlotte Mccarthy,M Snyder,R Parker (1965). The indigenous oral flora of man—I.
  3. J Carlsson,H Grahnén,G Jonsson,S Wikner (1970). Early stablisment of Streptococcus salivarius in the mouth of infants.
  4. J Tagg,L Bannister (1979). Fingerprint" betahemolytic streptococci by their production of and sensitivity to bacteriocin-like inhibitors.
  5. M Sahin,M Yalcin,D Kocyigit (2016). Prevalence of rheumatic heart disease in patients with recurrent tonsillitis and elevated anti-streptolysin O titers.
  6. P Wescombe,N Heng,J Burton,C Chilcott,J Tagg (2009). Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics.
  7. Francesco Di Pierro,Maria Colombo,Alberto Zanvit,Paolo Risso,Amilcare Rottoli (2016). Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in children.
  8. Francesco Di Pierro,Paolo Risso,Elena Poggi,Anna Timitilli,Sara Bolloli,Maurizio Bruno,Egidio Caneva,Riccardo Campus,Alessandro Giannattasio (2018). Use of Streptococcus salivarius K12 to reduce the incidence of pharyngo-tonsillitis and acute otitis media in children: a retrospective analysis in not-recurrent pediatric subjects.
  9. Ignazio La Mantia,Attilio Varricchio,Giorgio Ciprandi (2017). Bacteriotherapy with <em>Streptococcus salivarius</em> 24SMB and <em>Streptococcus oralis</em> 89a nasal spray for preventing recurrent acute otitis media in children: a real-life clinical experience.
  10. T Igarashi,Y Yano,A Yamamoto,R Sasa,N Goto (2001). Identification of Streptococcus salivarius by PCR and DNA probe.
  11. (2008). Hemostasis.
  12. J Burton,C Chilcott,P Wescombe,J Tagg (2010). Extended Safety Data for the Oral Cavity Probiotic Streptococcus salivarius K12.
  13. Mary Marquart,Angela Benton,Regina Galloway,Lisa Stempak (2018). Antibiotic susceptibility, cytotoxicity, and protease activity of viridans group streptococci causing endophthalmitis.
  14. (2001). Unknown Title.
  15. Colin Hill,Francisco Guarner,Gregor Reid,Glenn Gibson,Daniel Merenstein,Bruno Pot,Lorenzo Morelli,Roberto Canani,Harry Flint,Seppo Salminen,Philip Calder,Mary Sanders (2014). The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic.
  16. Julia Frick,Kerstin Fink,Frauke Kahl,Maria Niemiec,Matteo Quitadamo,Katrin Schenk,Ingo Autenrieth (2007). Identification of Commensal Bacterial Strains That Modulate <i>Yersinia enterocolitica</i> and Dextran Sodium Sulfate-Induced Inflammatory Responses: Implications for the Development of Probiotics.
  17. Roberta De Grandi,Lorenzo Drago,Alessandro Bidossi,Marta Bottagisio,Matteo Gelardi,Elena De Vecchi (2019). Putative Microbial Population Shifts Attributable to Nasal Administration of Streptococcus salivarius 24SMBc and Streptococcus oralis 89a.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Vera Fantinato. 2020. \u201cStreptococcus Salivarius Subsp Salivarius BIO5 – Toxicity Evaluation of a Possible Probiotic Strain\u201d. Global Journal of Medical Research - J: Dentistry & Otolaryngology GJMR-J Volume 20 (GJMR Volume 20 Issue J2): .

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-J Classification: NLMC Code: WC 210
Version of record

v1.2

Issue date

May 1, 2020

Language
en
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 2291
Total Downloads: 1239
2026 Trends
Related Research

Published Article

Probiotic bacteria, which are traditionally studied to aid intestinal functions, are also currently being researched for benefits in other parts of the body such as the oral cavity. In the case of throat infections caused by bacteria, which traditional treatment involves antibiotics, some researchers are studying the possibility of introducing special strains of commensal bacteria into the mouth that can specifically inhibit the tonsillitis agent Streptococcus pyogenes for both prevention and treatment of such disease. A PCR assay was used to identify Streptococcus salivarius subsp salivarius. Therefore, tests for the complete absence of toxicity of these strains are required to ensure their safe use in human trials. In this research, we evaluated the new Streptococcus salivarius subsp salivarius BIO5 strain for toxicity factors, as follows: clinical, ophthalmic lesions, behavioral observations, mortality, anatomopathological examination, biopsy, hematology, serum biochemistry, and urine analysis. This strain, isolated from the oral cavity and with bacteriocinogenic activity against S. pyogenes, showed a complete absence of toxicity and thus it may be used in replacement therapy as a probiotic.

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Streptococcus Salivarius Subsp Salivarius BIO5 – Toxicity Evaluation of a Possible Probiotic Strain

Vera Fantinato
Vera Fantinato
Camargo HR
Camargo HR
Sousa ALOPilleggi
Sousa ALOPilleggi

Research Journals